版本:
中国

BRIEF-Health Canada grants approval for Ocaliva

May 25 Intercept Pharmaceuticals Inc

* Health Canada grants approval for Ocaliva (obeticholic acid) for the treatment of patients with primary biliary cholangitis (pbc)

* Health Canada granted a conditional approval for Ocaliva for treatment of primary biliary cholangitis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐